Genomic Determinants of Responses to Immunotherapy in Merkel Cell Carcinoma

Project: Research project

Project Details


We will utilize genome sequencing to identify the genetic causes of primary and acquired resistance of Merkel cell carcinomas to immunotherapy.
Effective start/end date7/1/196/30/21


  • National Comprehensive Cancer Network (Agmt 6/24/19)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.